BioLife Solutions, Inc. (BLFS)

NASDAQ: BLFS · IEX Real-Time Price · USD
11.76
-1.00 (-7.84%)
May 18, 2022 11:54 AM EDT - Market open
Market Cap498.74M
Revenue (ttm)138.53M
Net Income (ttm)-13.58M
Shares Out42.41M
EPS (ttm)-0.20
PE Ration/a
Forward PE666.67
Dividendn/a
Ex-Dividend Daten/a
Volume140,490
Open12.50
Previous Close12.76
Day's Range11.76 - 12.73
52-Week Range10.40 - 60.67
Beta1.75
AnalystsBuy
Price Target47.30 (+302.2%)
Earnings DateMay 9, 2022

About BLFS

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line ...

IndustryHealth Care Equipment & Supplies
IPO DateNov 22, 1989
CEOMichael Rice
Employees432
Stock ExchangeNASDAQ
Ticker SymbolBLFS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for BLFS stock is "Buy." The 12-month stock price forecast is 47.3, which is an increase of 302.21% from the latest price.

Price Target
$47.3
(302.21% upside)
Analyst Consensus: Buy
Stock Forecasts

News

BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Lags Revenue Estimates

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 29.17% and 4.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

BioLife Solutions Reports First Quarter 2022 Financial Results

Revenue of $36.2 million increased 115% over Q1 2021, with organic revenue growth of 45% and biopreservation media revenue growth of 53% Affirms 2022 revenue guidance of $159.5 million to $171.0 million...

1 week ago - PRNewsWire

BioLife Solutions Executes Co-Marketing Agreement with Coriell Institute for Medical Research to Offer Biostorage, Bi...

BOTHELL, Wash. , May 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and bro...

1 week ago - PRNewsWire

BioLife Solutions to Report First Quarter 2022 Financial Results and Provide Business Update on May 9, 2022

BOTHELL, Wash. , May 2, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and bro...

2 weeks ago - PRNewsWire

New Strong Sell Stocks for May 2nd

ALEC, AMRS, and BLFS have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2022

Other symbols:ALECAMRS
2 weeks ago - Zacks Investment Research

BioLife Solutions, Inc. Announces Change of Auditor to Grant Thornton LLP

BOTHELL, Wash. , April 7, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...

1 month ago - PRNewsWire

New Strong Sell Stocks for March 31st

BLFS, CRNT, and AMBA have been added to the Zacks Rank #5 (Strong Sell) List on March 31, 2022.

Other symbols:AMBACRNT
1 month ago - Zacks Investment Research

BioLife Solutions Receives Nasdaq Notice of Noncompliance for Delayed 10-K Filing

BOTHELL, Wash. , March 18, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...

1 month ago - PRNewsWire

BioLife Solutions Announces Additional Delay in Filing of Annual Report on Form 10-K

BOTHELL, Wash., March 17, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...

2 months ago - PRNewsWire

BioLife Solutions Secures Strategic Customer Wins and Plans 2022 Expansion in $400 Million Biostorage Services Market

BOTHELL, Wash. , March 15, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and ...

2 months ago - PRNewsWire

BioLife Solutions to Attend and Present at Upcoming Investor Conferences

BOTHELL, Wash., March 1, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services ...

2 months ago - PRNewsWire

BioLife Solutions, Inc. (BLFS) Reports Q4 Loss, Tops Revenue Estimates

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of -131.25% and 0.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

BioLife Solutions Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results

BOTHELL, Wash. , Feb. 28, 2022 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and servic...

2 months ago - PRNewsWire

BioLife Solutions to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on Februa...

BOTHELL, Wash., Feb. 21, 2022 /PRNewswire/ --  BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and b...

2 months ago - PRNewsWire

PETQ or BLFS: Which Is the Better Value Stock Right Now?

PETQ vs. BLFS: Which Stock Is the Better Value Option?

Other symbols:PETQ
3 months ago - Zacks Investment Research

BioLife Sciences Inc. (OTC Markets: BLFE) Announced Today That the Company Has Finalized a Definitive Agreement With ...

Henderson, Nevada, Feb. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has finalized a definitive agreement (the “Agreement”) with Health ...

3 months ago - GlobeNewsWire

Best Biotech Stocks to Invest in Now

Try your hand at morphing science and business for a great investment opportunity in biotech.

Other symbols:INCYSGEN
3 months ago - MarketBeat

BioLife Solutions Announces Preliminary 2021 Revenue of $119 Million, Up 148% Over 2020

BOTHELL, Wash., Jan. 10, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broade...

4 months ago - PRNewsWire

BioLife Solutions Collaborates with Seattle Children's to Improve Viral Vector and Cell and Gene Therapy Manufacturing

BOTHELL, Wash., Jan. 4, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader bioph...

4 months ago - PRNewsWire

UNICEF Selects Ultra-Low Temperature (ULT) Freezers from BioLife Solutions to Extend Thermal Stability of COVID-19 Va...

BOTHELL, Wash., Dec. 16, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and br...

5 months ago - PRNewsWire

BioLife Solutions Ranks 353 Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™

BOTHELL, Wash., Nov. 17, 2021 /PRNewswire/ --  BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and b...

6 months ago - PRNewsWire

BioLife Solutions Named to Inc. Magazine Inaugural List of Best-Led Companies

BOTHELL, Wash., Nov. 15, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...

6 months ago - PRNewsWire

BioLife Solutions Announces Third Quarter 2021 Financial Results

BOTHELL, Wash., Nov. 11, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...

6 months ago - PRNewsWire

BioLife Solutions Announces Executive Management Changes

BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies...

6 months ago - PRNewsWire

BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021

BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and bro...

6 months ago - PRNewsWire